FOLLOW US

FOLLOW US

Monday-Friday: 7AM-5PM
Saturday: 8AM-1PM

Postpartum Depression Treatment

Zulresso R ( Brexanolone)

Zulresso R ( Brexanolone)

ZULRESSO, the first medicine specifically approved by the U.S. Food and Drug Administration for the treatment of postpartum depression. Postpartum depression (PPD) is the most common medical complication of childbirth. PPD is a distinct and readily identified major depressive disorder that can occur during pregnancy or after giving birth. Contact us to learn more about this amazing FDA approved medicine for those suffering from PPD.

Postpartum depression (PPD) is the most common medical complication of childbirth. PPD is a distinct and readily identified major depressive episode that can occur during pregnancy or after giving birth. PPD may have devastating consequences for a woman and for her family, which may include significant functional impairment, depressed mood and/or loss of interest in her newborn, and associated symptoms of depression such as loss of appetite, difficulty sleeping, motor challenges, lack of concentration, loss of energy and poor self-esteem. PPD can be a life-threatening condition due to the risk of suicide, a leading cause of maternal death following childbirth.

Client Testimonials

Schedule An Appointment

Previous Next
Close
Test Caption
Test Description goes like this